Maricel Apuli, Chief Accounting Officer at BridgeBio Pharma, Inc. (BBIO), sold 1,026 shares at $38.51 ($40K) on 2025-05-02, disclosed to the SEC on 2025-05-06.
Open-market sale of $40k BBIO by Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BBIO | SELL | 2026-02-27 | $132K | — | Filing → |
| BBIO | SELL | 2026-02-18 | $38K | — | Filing → |
| BBIO | SELL | 2025-12-10 | $149K | — | Filing → |